Á lódáil...
Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
The central importance of angiogenesis and our understanding of how new blood vessels are formed have led to the development of novel antiangiogenic therapies. Although the number of agents in development has grown exponentially, only one phase III trial in breast cancer has been completed. In that...
Na minha lista:
| Foilsithe in: | Breast Cancer Res |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BMC
2004
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400679/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15084233/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr782 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|